Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

Autor: Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort-Marti, Francis JB Kynaston-Pearson

Publikováno v: The Cochrane Database of Systematic Reviews
The Cochrane Library
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background\ud Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) for reducing the risk of joint damage, improving physical function and improving the quality of life. This review is an update o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eedae4ff68f0cdc8415b09bee9cc824a
https://doi.org/10.1002/14651858.cd007649.pub3